Comparative study of mouse models of atopic dermatitis

Comparative study of mouse models of atopic dermatitis

Atopic dermatitis (AD) is a chronic, recurrent inflammatory disease. Animal models are important for studying disease mechanisms and identifying new therapeutic agents. However, owing to AD heterogeneity and complexity, there is currently no mouse model that can fully simulate human AD. We searched...

Full description

Saved in:

Bibliographic Details
Main Authors:	Siqi Ye, Lian Zhu, Tao Ruan, Jinjing Jia, Xiumei Mo, Fenggen Yan, Junfeng Liu, Yu Zhang, Dacan Chen
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Heliyon
Subjects:	Atopic dermatitis Murine model 2,4-Dinitrochlorobenzene Mouse strains
Online Access:	http://www.sciencedirect.com/science/article/pii/S240584402500369X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01)

Mistakes in the diagnosis and treatment of atopic dermatitis
by: Monika Marko, et al.
Published: (2024-02-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Unmet needs in atopic dermatitis management: an expert consensus
by: Annalisa Patrizi, et al.
Published: (2022-07-01)

Determining atopic dermatitis adult patients’ preferences regarding novel systemic treatment
by: Monika Suszynska, et al.
Published: (2025-01-01)

Allergen immunotherapy in atopic dermatitis
by: Agnieszka Bogacz-Piaseczyńska, et al.
Published: (2024-08-01)

Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index
by: Gabriele Di Lorenzo, et al.
Published: (2003-01-01)

Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life
by: Andrew Blauvelt, et al.
Published: (2022-07-01)

The role of exogenous histamine in atopic dermatitis flare-ups
by: Zofia Kowalska, et al.
Published: (2024-08-01)

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)
by: Marjolein de Bruin-Weller, et al.
Published: (2022-07-01)

Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
by: Ahmad Vafaeian, et al.
Published: (2025-02-01)

Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
by: Lauletta G, et al.
Published: (2025-01-01)

A Study on the Classification of Atopic Dermatitis by Spectral Features of Hyperspectral Imaging
by: Eun Bin Kim, et al.
Published: (2025-01-01)

Atopic dermatitis in childhood and pubertal development: A nationwide cohort studyCapsule Summary
by: Camilla Lomholt Kjersgaard, MD, et al.
Published: (2025-04-01)

The epidermal lipid-microbiome loop and immunity: Important players in atopic dermatitis
by: Junchao Wu, et al.
Published: (2025-02-01)

Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
by: Filip Rob, et al.
Published: (2025-12-01)

Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis
by: Verónica Sánchez-García, et al.
Published: (2025-02-01)

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
by: Liu J, et al.
Published: (2025-02-01)

Restorative effects of camellia oil on the skin-barrier function in a model of DNCB-induced atopic dermatitis
by: Shicheng Jiao, et al.
Published: (2025-01-01)

Based on network pharmacology and molecular docking to study the mechanisms of active ingredients of ginseng in the treatment of atopic dermatitis
by: BU Jialiang, et al.
Published: (2025-01-01)

Genomic epidemiology and phenotypic characterization of Staphylococcus aureus isolated from atopic dermatitis patients in South China
by: Chao Yang, et al.
Published: (2025-02-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01)

Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
by: Stamatios Gregoriou, et al.
Published: (2025-01-01)

Patients’ preferences on atopic dermatitis skincare and social media use: a qualitative study
by: Roxana Mazilu, et al.
Published: (2025-02-01)

Connecting electronic health records to a biomedical knowledge graph to link clinical phenotypes and molecular endotypes in atopic dermatitis
by: Francesca Frau, et al.
Published: (2025-01-01)

<i>Aspergillus oryzae</i> Fermented <i>Plumula Nelumbinis</i> Against Atopic Dermatitis Through AKT/mTOR and Jun Pathways
by: Fengfeng Chen, et al.
Published: (2024-12-01)

A Comparative Study to Evaluate the Effectiveness between Synergic Activities of 0.1% Polyhexanide and Rigenase® (Fitostimoline® Plus spray) versus a Hydrating Formulation for the Topical Management of Rubbing Injuries Secondary to Atopic Dermatitis
by: Eugenia Veronica Di Brizzi, et al.
Published: (2025-01-01)

Anti-inflammatory and antioxidant properties of Camellia sinensis L. extract as a potential therapeutic for atopic dermatitis through NF-κB pathway inhibition
by: Min Jung Kim, et al.
Published: (2025-01-01)

Thymus and activation-regulated chemokine (CCL17) as a clinical biomarker in atopic dermatitis: significance and limitations in the new treatment era
by: Yoko Kataoka
Published: (2025-01-01)

Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
by: Eri Uchiyama, et al.
Published: (2025-01-01)

The Anti-Inflammatory Effect of Chenopodium Murale in Comparison to Salvia Frigida on Atopic Eczema
by: Zahraa Y. Hassan, et al.
Published: (2024-12-01)

Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children
by: Eric L. Simpson, et al.
Published: (2025-01-01)

Case Report: Severe ophiasis-pattern alopecia areata with concomitant atopic dermatitis in a 5-year-old boy successfully treated with dupilumab
by: Zhendong Wei, et al.
Published: (2025-02-01)

Exploration of the mechanism of Lithospermum erythrorhizon oil in treating atopic dermatitis based on network pharmacology and experimental validation of the PI3K-Akt pathway regulation
by: Weisheng Hu, et al.
Published: (2025-01-01)

ATOP
by: Syd Bauman, et al.
Published: (2023-05-01)

Anti-Inflammatory Potential and Synergic Activities of <i>Eclipta prostrata</i> (L.) L. Leaf-Derived Ointment Formulation in Combination with the Non-Steroidal Anti-Inflammatory Drug Diclofenac in Suppressing Atopic Dermatitis (AD)
by: Muhammad M. Poyil, et al.
Published: (2024-12-01)

Is the Increase in Tumour Markers and Hashimoto’s Thyroiditis an Incidental Event During Dupilumab Treatment? A Case Report
by: Kesheng Lin, et al.
Published: (2025-02-01)

An Overview of the Skin Microbiome, the Potential for Pathogen Shift, and Dysbiosis in Common Skin Pathologies
by: Anita Smith, et al.
Published: (2025-01-01)

Scratch Scoring by a Sheet-shaped Body Vibrometer in Nocturnal Sleep: A Pilot Study Compared with Infrared Video Recording
by: Saori Toyota, et al.
Published: (2025-01-01)

Incidence of Young People Mental Health Disorders with Atopic Dermatitis during the COVID-19 Pandemic
by: Alison Monserrat Culqui Tapia, et al.
Published: (2022-12-01)